Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for brain cancer diagnostics by test type
5.1 Imaging test (MRI, CT, PET)
5.1.1 Market size and forecast
5.2 Lumbar puncture
5.2.1 Market size and forecast
5.3 Biopsy
5.3.1 Market size and forecast
5.4 Molecular testing
5.4.1 Market size and forecast
5.5 Others
5.5.1 Market size and forecast

Part 6. Global market for brain cancer diagnostics by cancer type
6.1 Glioblastoma multiforme
6.1.1 Market size and forecast
6.2 Astrocytomas
6.2.1 Market size and forecast
6.3 Ependymomas
6.3.1 Market size and forecast
6.4 Others
6.4.1 Market size and forecast

Part 7. Global market for brain cancer diagnostics by end user
7.1 Hospitals & clinics
7.1.1 Market size and forecast
7.2 Ambulatory surgical centers (ASCs)
7.2.1 Market size and forecast
7.3 Others
7.3.1 Market size and forecast

Part 8. Global market for brain cancer diagnostics by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast

Part 9. Key competitor profiles
9.1 Biocept, Inc.
9.2 Canon Medical Systems Corporation
9.3 GE Healthcare
9.4 Hitachi, Ltd.
9.5 Koninklijke Philips N.V.
9.6 NantOmics, LLC
9.7 Neusoft Medical Systems Co., Ltd.
9.8 Siemens Healthineers AG
9.9 Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY